Use of Chewing Gum to Facilitate Appetite Control and Weight Loss
NCT ID: NCT00871676
Last Updated: 2016-08-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
146 participants
INTERVENTIONAL
2006-05-31
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chewing Gum for Weight Loss
NCT00971347
A Study of Chewing Gum, Snacking and Appetite
NCT01316991
The Effects of Gum Chewing on Energy Intake and Expenditure
NCT01043471
Increasing in Chewing Number Reduces Energy Intake in Healthy Weight and Overweight Young Adults
NCT03342313
The Effects of Exercise on Appetite Regulation in Overweight/Obese Individuals
NCT02047721
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Overweight/obese individuals being treated with lifestyle modification to facilitate weight loss.
Lifestyle modification
16 weekly followed by 8 monthly group behavioral weight loss sessions.
2
Lifestyle modification plus use of chewing gum to facilitate weight loss in overweight/obese persons.
Lifestyle modification plus gum
16 weekly followed by 8 monthly group behavioral weight loss sessions. Subjects were also given gum along with instructions for times and occasions to chew with the aim of facilitating weight loss and appetite control.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lifestyle modification
16 weekly followed by 8 monthly group behavioral weight loss sessions.
Lifestyle modification plus gum
16 weekly followed by 8 monthly group behavioral weight loss sessions. Subjects were also given gum along with instructions for times and occasions to chew with the aim of facilitating weight loss and appetite control.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Body Mass Index of 25-45 inclusive
Exclusion Criteria
* medications know to effect weight
* full or partial dentures
* 18 or fewer teeth
* regular gum chewing (≥ 2 pieces/day)
* use of any tobacco product
* sensitivity to the following ingredients (mint, magnolia bark, eggs, or English Muffins)
* history of PKU
* sensitivity or allergy to aspartame
* current/history of alcohol abuse or addiction (within 5 year)
* recreational drug use
* recent significant weight change (+/- 5% in previous 6 months)
* currently pregnant or nursing and willingness not to get pregnant during course of study
* participation in any other research studies
* proximity to clinic (within one hour)
* access to reliable transportation
21 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Luke's-Roosevelt Hospital Center
OTHER
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
William Wrigley Jr. Company
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas A Wadden, Ph.D
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
804361
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.